These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17336005

  • 1. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
    Wei G, Lu LF, Lu WY.
    Int J Pharm; 2007 Jun 29; 338(1-2):125-32. PubMed ID: 17336005
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK, Chung HJ, Park TG.
    J Control Release; 2006 May 15; 112(2):167-74. PubMed ID: 16542746
    [Abstract] [Full Text] [Related]

  • 3. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C, Griebenow K.
    Biotechnol Bioeng; 2003 Jun 30; 82(7):825-32. PubMed ID: 12701149
    [Abstract] [Full Text] [Related]

  • 4. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT, Su HB, Li GP, Tao XM, Mo W, Song HY.
    Int J Pharm; 2006 Feb 17; 309(1-2):101-8. PubMed ID: 16413979
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J, Wu F, Cai Y, Xu M, He M, Yuan W.
    Eur J Pharm Sci; 2014 Oct 01; 62():141-7. PubMed ID: 24907681
    [Abstract] [Full Text] [Related]

  • 8. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL, Jones AJ.
    Pharm Res; 1996 Oct 01; 13(10):1464-75. PubMed ID: 8899836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S, Kurokawa T, Misaki M, Taira K, Yamagata Y.
    J Pharm Pharmacol; 2003 Jul 01; 55(7):951-61. PubMed ID: 12906752
    [Abstract] [Full Text] [Related]

  • 14. The stabilization and encapsulation of human growth hormone into biodegradable microspheres.
    Johnson OL, Jaworowicz W, Cleland JL, Bailey L, Charnis M, Duenas E, Wu C, Shepard D, Magil S, Last T, Jones AJ, Putney SD.
    Pharm Res; 1997 Jun 01; 14(6):730-5. PubMed ID: 9210189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT, Tao XM, Mo W, Song HY.
    Yao Xue Xue Bao; 2006 Jan 01; 41(1):12-8. PubMed ID: 16683521
    [Abstract] [Full Text] [Related]

  • 18. Development of a sustained-release recombinant human growth hormone formulation.
    Kwak HH, Shim WS, Choi MK, Son MK, Kim YJ, Yang HC, Kim TH, Lee GI, Kim BM, Kang SH, Shim CK.
    J Control Release; 2009 Jul 20; 137(2):160-5. PubMed ID: 19332090
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.